PURPOSE: Investigation of cell migration and proliferation of human glioma cell line spheroids (CLS) and evaluation of morphology, apoptosis, and immunohistochemical expression of MIB-1, p53, and p21 of organotypic muticellular spheroids (OMS) following cisplatin (CDDP) and irradiation (RT). MATERIAL AND METHODS: Spheroids of the GaMg glioma cell line and OMS prepared from biopsy tissue of six glioblastoma patients were used. Radiochemosensitvity (5 microg/ml CDDP followed by RT) was determined using migration and proliferation assays on CLS. In OMS, histology and immunohistochemical studies of MIB-1, p53, and p21 expression were examined 24 and 48 h following treatment. RESULTS: Combination treatment led to a migration inhibition of 38% (CDDP 13%; RT 27%) and specific growth delay of 2.6 (CDDP 1.3; RT 2.1) in CLS. Cell cycle analysis after combination treatment showed an accumulation of cells in the G2/M phase. In OMS, apoptosis increased, cell proliferation decreased, and p53/p21 expression increased more pronounced following CDDP+RT. No morphological damage was observed. CONCLUSION: CDDP can lead to enhancement of the RT effect in spheroids of both human glioma cell line spheroids and biopsy spheroids from glioblastoma specimens. The exerted effect is additive rather than synergistic.
PURPOSE: Investigation of cell migration and proliferation of humanglioma cell line spheroids (CLS) and evaluation of morphology, apoptosis, and immunohistochemical expression of MIB-1, p53, and p21 of organotypic muticellular spheroids (OMS) following cisplatin (CDDP) and irradiation (RT). MATERIAL AND METHODS: Spheroids of the GaMg glioma cell line and OMS prepared from biopsy tissue of six glioblastomapatients were used. Radiochemosensitvity (5 microg/ml CDDP followed by RT) was determined using migration and proliferation assays on CLS. In OMS, histology and immunohistochemical studies of MIB-1, p53, and p21 expression were examined 24 and 48 h following treatment. RESULTS: Combination treatment led to a migration inhibition of 38% (CDDP 13%; RT 27%) and specific growth delay of 2.6 (CDDP 1.3; RT 2.1) in CLS. Cell cycle analysis after combination treatment showed an accumulation of cells in the G2/M phase. In OMS, apoptosis increased, cell proliferation decreased, and p53/p21 expression increased more pronounced following CDDP+RT. No morphological damage was observed. CONCLUSION:CDDP can lead to enhancement of the RT effect in spheroids of both humanglioma cell line spheroids and biopsy spheroids from glioblastoma specimens. The exerted effect is additive rather than synergistic.
Authors: Fabian Fehlauer; Lukas J A Stalpers; John Panayiotides; Patricia Kaaijk; Dionisio González González; Sieger Leenstra; Paul van der Valk; Peter Sminia Journal: Oncol Rep Date: 2004-02 Impact factor: 3.906
Authors: Sergey V Sheleg; Eugeny A Korotkevich; Edvard A Zhavrid; Galina V Muravskaya; Arnold F Smeyanovich; Yury G Shanko; Tatsiana L Yurkshtovich; Pavel B Bychkovsky; Sergey A Belyaev Journal: J Neurooncol Date: 2002-10 Impact factor: 4.130
Authors: Jan Gliemroth; Thomas Feyerabend; Christiane Gerlach; Hans Arnold; A Jorge A Terzis Journal: Neurosurg Rev Date: 2003-02-12 Impact factor: 3.042
Authors: A Taghian; J Ramsay; J Allalunis-Turner; W Budach; D Gioioso; F Pardo; P Okunieff; N Bleehen; R Urtasun; H Suit Journal: Int J Radiat Oncol Biol Phys Date: 1993-01-15 Impact factor: 7.038
Authors: C E Kleynen; T R Stoter; T M Tadema; L J Stalpers; C M Dirven; S Leenstra; P Van Der Valk; B J Slotman; P Sminia Journal: Anticancer Res Date: 2003 Nov-Dec Impact factor: 2.480
Authors: Maria F Gencoglu; Lauren E Barney; Christopher L Hall; Elizabeth A Brooks; Alyssa D Schwartz; Daniel C Corbett; Kelly R Stevens; Shelly R Peyton Journal: ACS Biomater Sci Eng Date: 2017-03-13
Authors: Charlotte Aaberg-Jessen; Annette Nørregaard; Karina Christensen; Christian B Pedersen; Claus Andersen; Bjarne W Kristensen Journal: Int J Clin Exp Pathol Date: 2013-03-15